1. Home
  2. EXPO vs VKTX Comparison

EXPO vs VKTX Comparison

Compare EXPO & VKTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Exponent Inc.

EXPO

Exponent Inc.

HOLD

Current Price

$66.75

Market Cap

3.3B

ML Signal

HOLD

Logo Viking Therapeutics Inc.

VKTX

Viking Therapeutics Inc.

HOLD

Current Price

$28.85

Market Cap

3.4B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
EXPO
VKTX
Founded
1967
2012
Country
United States
United States
Employees
N/A
51
Industry
Professional Services
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
3.3B
3.4B
IPO Year
1990
2015

Fundamental Metrics

Financial Performance
Metric
EXPO
VKTX
Price
$66.75
$28.85
Analyst Decision
Buy
Strong Buy
Analyst Count
3
11
Target Price
$90.50
$89.27
AVG Volume (30 Days)
463.6K
3.2M
Earning Date
02-05-2026
02-11-2026
Dividend Yield
1.86%
N/A
EPS Growth
N/A
N/A
EPS
2.07
N/A
Revenue
$536,760,000.00
N/A
Revenue This Year
$12.18
N/A
Revenue Next Year
$8.47
N/A
P/E Ratio
$32.27
N/A
Revenue Growth
3.52
N/A
52 Week Low
$63.81
$18.92
52 Week High
$91.41
$43.15

Technical Indicators

Market Signals
Indicator
EXPO
VKTX
Relative Strength Index (RSI) 38.40 47.27
Support Level $69.00 $27.17
Resistance Level $81.95 $34.38
Average True Range (ATR) 3.74 1.75
MACD -0.69 0.18
Stochastic Oscillator 6.97 51.34

Price Performance

Historical Comparison
EXPO
VKTX

About EXPO Exponent Inc.

Exponent Inc is a science and engineering consulting firm that provides solutions to complex problems. The company's consultant team is composed of scientists, physicians, engineers, as well as business and regulatory consultants. The company currently operates through two segments. The engineering and other scientific segments, which account for the majority of revenue, provide servicing encompassing biomechanics, biomedical engineering, buildings and structures, civil engineering, construction consulting, etc. The environmental and health segment covers chemical regulation and food safety, ecological and biological sciences, environmental and earth sciences and others. The company generates almost all of its revenues from America.

About VKTX Viking Therapeutics Inc.

Viking Therapeutics Inc is a healthcare service provider. The company specializes in the area of biopharmaceutical development focused on metabolic and endocrine disorders. The company's clinical program pipeline consists of VK2809, VK5211, and VK0214 products. VK2809 and VK0214 are orally available, tissue and receptor-subtype-selective agonists of the thyroid hormone receptor beta. VK5211 is an orally available, non-steroidal selective androgen receptor modulator.

Share on Social Networks: